Skip to main content

Advertisement

SpringerLink
Log in

Von Hippel-Lindau Syndrome: the Family Clinical Case and Brief Review of the Literature

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

Von Hippel-Lindau syndrome (VHLS) (VON HIPPEL-LINDAU SYNDROME; VHLS OMIM # 193,300) is an inherited familial cancer predisposition syndrome caused by mutations in the VHL gene located on 3p25.3. It is a rare hereditary autosomal dominant disease with a population frequency of one in 36,000 people. VHLS is characterized by a predisposition to the development of different types of tumors with several localizations, such as visceral and central nervous system (hemangioblastoma, paraganglioma), pheochromocytoma, pancreatic cancer cell carcinoma, adenocarcinoma of ampulla of vater, hypernephroma, and kidney cancer. Affected individuals have a high lifetime risk of tumor developing—over 90% penetrance by 65 years. Herein, we present a case of a native Caucasian woman with multiple pancreatic and kidney cysts and nonsense genetic variant c.203C > A (p.S68*) in VHL gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

VHLS:

Von Hippel-Lindau syndrome

CNS:

Central nervous system

HGB:

Hemangioblastoma

PHEO:

Pheochromocytoma

RCC:

Renal cell carcinoma

ACMG:

American College of Medical Genetics and Genomics

VHLA:

VHL Alliance

Sa:

Sarcoma

References

  1. Rasmussen, A., Alonso, E., Ochoa, A., De Biase, I., Familiar, I., Yescas, P., et al. (2010). Uptake of genetic testing and long-term tumor surveillance in Von Hippel-Lindau disease. BMC Medical Genetics, 11, 4. https://doi.org/10.1186/1471-2350-11-4

    Article  Google Scholar 

  2. Maher, E., Neumann, H., & Richard, S. (2011). Von Hippel-Lindau disease: A clinical and scientific review. European Journal of Human Genetics, 19(6), 617–623. https://doi.org/10.1038/ejhg.2010.175

    Article  Google Scholar 

  3. Friedrich, C. (1999). Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer, 86(11 Suppl), 2478–2482.

    Article  Google Scholar 

  4. Lonser, R., Glenn, G., Walther, M., Chew, E., Libutti, S., Linehan, W., et al. (2003). Von Hippel-Lindau disease. Lancet, 361(9374), 2059–67. https://doi.org/10.1016/S0140-6736(03)13643-4

    Article  Google Scholar 

  5. Varshney, N., Kebede, A., Owusu-Dapaah, H., Lather, J., Kaushik, M., & Bhullar, J. (2017). A review of Von Hippel-Lindau syndrome. Journal of Kidney Cancer and VHL, 4(3), 20–29.

    Article  Google Scholar 

  6. Maher, E. R., Neumann, H. P., & Richard, S. (2011). von Hippel-Lindau disease: A clinical and scientific review. European of Journal Human Genetics, 19(6), 617–23.

    Article  Google Scholar 

  7. Iliopoulos, O., Ohh, M., & Kaelin, W. (1998). pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proceedings National Academy of Sciences of the United States of America, 95, 11661–6. https://doi.org/10.1073/pnas.95.20.11661

    Article  Google Scholar 

  8. Semenza, G. (2011). (2011) Oxygen sensing, homeostasis, and disease. New England Journal of Medicine, 365(6), 537–547. https://doi.org/10.1056/NEJMra1011165

    Article  Google Scholar 

  9. Couch, V., Lindor, N., Karnes, P., & Michels, V. (2000). Von Hippel-Lindau disease. Mayo Clinic Proceedings, 75(3), 265–272.

    Article  Google Scholar 

  10. Nordstrom-O’Brien, M., van der Luijt, R., van Rooijen, E., van den Ouweland, A., Majoor-Krakauer, D., Lolkema, M., et al. (2010). Genetic analysis of Von Hippel-Lindau disease. Human Mutation, 31(5), 521–537. https://doi.org/10.1002/humu.21219

    Article  Google Scholar 

  11. Choyke, P., Glenn, G., Walther, M., Patronas, N., Linehan, W., & Zbar, B. (1995). Von Hippel-Lindau disease: Genetic, clinical, and imaging features. Radiology, 194(3), 629–642. https://doi.org/10.1148/radiology.194.3.7862955

    Article  Google Scholar 

  12. Ganeshan, D., Menias, C., Pickhardt, P., et al. (2018). Tumors in von Hippel-Lindau syndrome: From head to toe-comprehensive state-of-the-art review. Radiographics, 38(3), 849–866. https://doi.org/10.1148/rg.2018170156Crespigio

    Article  Google Scholar 

  13. Maher, E., Yates, J., Harries, R., Benjamin, C., Harris, R., Moore, A., et al. (1990). Clinical features and natural history of Von Hippel-Lindau disease. The Quarterly Journal of Medicine, 77(283), 1151–1163. https://doi.org/10.1093/qjmed/77.2.1151

    Article  Google Scholar 

  14. VHLA Suggested Active Surveillance Guidelines. (2020). https://www.vhl.org/wp-content/uploads/2020/10/Active-Surveillance-Guidelines-2020.pdf

  15. NCCN Clinical Practice Guidelines in Oncology. (2021). Kidney Cancer. Version 2.2022 https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf

  16. FDA approval of Welireg (belzutifan) for adult patients with von Hippel-Lindau disease. (2021). https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-welireg-belzutifan-adult-patients-von-hippel-lindau-disease-who#:~:text=On%20August%2013%2C%202021%2C%20FDA,tumors%2C%20not%20requiring%20immediate%20surgery

  17. Mikhailenko, D. S., Zhinzhilo, T. A., Kolpakov, A. V., Kekeeva, T. V., Strel’nikov, V. V., Nemtsova, M. V., et al. (2017). Specific localization of missense mutations in the VHL gene in clear cell renal cell carcinoma. Bulletin of Experimental Biology and Medicine, 163(4), 465–468. https://doi.org/10.1007/s10517-017-3829-4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Budgetary Healthcare Institution, The Loginov Moscow Clinical Scientific Center Under the Health Department of Moscow, Moscow, Russia

    A. Danishevich, M. Baychorov, S. Nikolaev, N. Orlova, I. Khatkov & N. Bodunova

  2. Kazan (Volga region) Federal University, Kazan, Russia

    A. Bilyalov

  3. Research Centre for Medical Genetics, Moscow, Russia

    D. Mikhaylenko

Authors
  1. A. Danishevich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bilyalov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Baychorov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Mikhaylenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Nikolaev
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Orlova
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Khatkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N. Bodunova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Bilyalov.

Ethics declarations

Informed Consent

Informed consent was signed by patient before the procedure.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to the Topical Collection: Molecular, Precision and Regenerative Medicine - 2021

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Danishevich, A., Bilyalov, A., Baychorov, M. et al. Von Hippel-Lindau Syndrome: the Family Clinical Case and Brief Review of the Literature. BioNanoSci. 12, 184–190 (2022). https://doi.org/10.1007/s12668-021-00933-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-021-00933-3

Keywords

Search

Navigation